NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

痤瘡治療藥的全球市場:2020年∼2027年

Global Acne Drugs Market - 2021-2028

出版商 DataM Intelligence 商品編碼 967419
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
痤瘡治療藥的全球市場:2020年∼2027年 Global Acne Drugs Market - 2021-2028
出版日期: 2021年06月14日內容資訊: 英文 180 Pages
簡介

痤瘡是一般皮膚疾病,在全球有940萬人以上罹患。主要的原因,是異常的荷爾蒙產生,由於青春期的雄激素(女性為雌激素)等級的上升造成皮膚下的皮脂腺擴大生成過剩的皮脂,破壞毛孔的細胞牆引起細菌侵入而發病。

由於遺傳的要素也有提高痤瘡的發病風險的可能性,不過,感情性壓力,高溫多濕的氣候,含大量脂質的化妝品等要素也可能有關聯。

本報告提供全球痤瘡治療藥市場調查,市場力學,產業分析,新型冠狀病毒感染疾病(COVID-19)的影響分析,各類型,各治療藥等級,各投藥法,各流通管道,各地區的分析,競爭情形,企業簡介等資訊。

目錄

第1章 調查手法和範圍

第2章 市場定義和概要

第3章 摘要整理

  • 各類型市場
  • 各治療藥等級市場
  • 各投藥法市場
  • 各流通管道市場
  • 各地區市場

第4章 市場力學

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 COVID-19的影響分析

  • COVID-19對市場的影響分析
    • 大流行前的市場方案
    • 目前市場方案
    • 大流行後或未來市場方案
  • Covid-19大流行下的價格趨勢
  • 供需情形
  • 大流行時的市場相關的各國政府舉措
  • 各製造公司的策略性舉措
  • 結論

第7章 市場分析:各類型

  • 簡介
  • 市場規模和與前一年同期比較成長率分析
  • 市場魅力指數
    • 尋常性*
    • 發炎性
    • 囊胞性
    • 手術後/創傷

第8章 市場分析:各治療藥等級

  • 簡介
  • 市場規模和與前一年同期比較成長率分析
  • 市場魅力指數
    • 類視色素*
    • 抗生素
    • 荷爾蒙劑
    • 並用
    • 其他

第9章 市場分析:各投藥法

  • 簡介
  • 市場規模和與前一年同期比較成長率分析
  • 市場魅力指數
    • 局部給藥*
    • 口服給藥
    • 注射

第10章 市場分析:各流通管道

  • 簡介
  • 市場規模和與前一年同期比較成長率分析
  • 市場魅力指數
    • 零售店*
    • 藥局,藥妝店
    • 網路商店

第11章 市場分析:各地區

  • 簡介
  • 市場規模和與前一年同期比較成長率分析
  • 市場魅力指數
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第12章 競爭情形

  • 競爭模式
  • 市場上的定位/佔有率分析
  • 合併和收購分析

第13章 企業簡介

  • Johnson & Johnson *
  • Allergan plc
  • Galderma S.A
  • Reckitt Benckiser Group
  • Guthy-Renker
  • Stiefel Laboratories
  • Valeant Pharmaceuticals
  • Bayer AG,
  • BioPharmX.
  • Mayne Pharma Group Limited

第14章 主要調查結果

第15章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMPH2739

Market Overview

The Global Acne Drugs Market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Acne drugs refer to the medicines used for healing a dermatological infection distinguished by the inflammation in the hair follicles on the skin. It is usually produced by oily skin, hormonal imbalance, and accumulation of dead skin cells, bacteria, stress, and intake, excessive consumption of sugars, inadequate water salts, or carbohydrates. It affected more than 9.4 million people worldwide.

Market Dynamics

The prevalence of acne diseases drives the global acne drugs market growth. Moreover, other factors that fuel the market include an unhealthy urban lifestyle and potent acne medications in the pipeline.

Increasing prevalence and severity of acne globally will drive the global market

Increasing prevalence and severity of acne globally will drive the market over the projection years. Acne vulgaris is the most common skin problem amongst the teenaged population, with women being affected at higher rates than men. According to the Global Burden of Disease study, acne vulgaris affects approximately 85% of young adults aged between 12-25 years.

The multifactorial disease of the pilosebaceous unit, acne vulgaris, has been found to exert huge psychosocial effects on adult female patients. The growing numbers of dermatology visits in various countries show. The significant morbidity of acne has propelled research on the pathological factors underlying promising acne therapies worldwide. Researchers' relentless efforts to unveil novel drug delivery systems have focused on reducing the systemic side effects of drugs administered through parenteral or oral routes. This factor constitutes the evolving dynamics of the acne drugs market.

Unhygienic lifestyle and excessive production of oil from sebaceous glands is driving the market growth

The fluctuating hormone levels, unhygienic lifestyle, and excessive oil production from sebaceous glands have increased the prevalence of acne, thereby positively affecting the market growth. In addition, western countries are more prone to acne due to the population's dietary regimen characterized by high amounts of sugar, refined grains, high protein, and high-fat dairy products, hence boosting the market growth.

Statistics acquired from acnetreatment.org.uk have revealed that 92% of patients suffering from acne have felt depression while 14% have felt suicidal tendencies. This factor creates immediate demand for acne treatments, which is expected to fuel revenues in the global acne drug market..

Risks associated with use of anti-acne drugs is likely to hinder the market growth

However, Off-label use of anti-acne drugs such as Diane-35 as birth-control measures may lead to severe consequences such as breast cancer and venous thromboembolism (VTE). Additionally, adverse effects associated with these drugs, such as nausea, high blood pressure, and congenital disabilities (as in the case of isotretinoin), continue to restrain the market.

COVID-19 Impact Analysis

The pandemic impacts the acne drugs market as most nations adopted lockdown to oppose the pandemic. This pandemic has interrupted growth in many economies over various regions. The COVID-19 pandemic has emphasized healthcare systems worldwide, and many dermatology clinics are no longer open for public assistance, owing to safety. Several clinics and hospitals have been transformed into COVID-19 centers using pandemic-designated hospital arrangements to treat and isolate patients with COVID-19. Furthermore, due to lockdown, many patients cannot visit dermatology clinics and pharmacies to pick up medicines. These factors are hampering the growth of the market in the forecast period.

Segment Analysis

Inflammatory acne segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Inflammatory acne is a condition that occurs when pores are deeply clogged, resulting in swelling and redness. Bacterial infection may further aggravate this condition. As an inflammatory breakout develops, more and more oil flows into your pores, allowing acne-causing bacteria (sometimes including Propionibacterium acnes or P. acnes) to flourish beneath the plug. This factor adds pressure to the pore, eventually breaking down and releasing bacteria into the surrounding skin. Whether mild to severe, all inflammatory acne breakouts start as a small pore blockage called a microcomedo. These blockages are minor than can be seen by the naked eye, but they eventually turn into that inflamed pimple you see on the skin. That's because that tiny plug stops up the opening of the pore.

Cystic acne is the most severe form and affects relatively fewer people.OTC drugs are not usually strong enough for treating cystic acne. Post-surgical/wound acne occurs as a consequence of bacterial infection at the site of wound/surgery. This acne most often affects adolescents and young adults, with an estimated 80 percent of people between 11 and 30 years of age experiencing acne at some point. In 2009, the Centers for Disease Control and Prevention (CDC) found that acne was the top reason people visited a dermatologist.

Retinoid segment are expected to dominate the acne drugs market, by therapeutic class, during the forecast period

Retinoids dominated the therapeutic classes. Retinoids are a class of chemically derived medications derived from vitamin A. Retinoids regulate several transcription factors like RXR and RAR located within the nucleus of various cells. Retinoids reduce the inflammation and restore the normal epidermal differentiation that is absent in psoriatic lesions. Retinoids are very helpful for many common skin problems but are not without risks like dryness and irritation, changes in skin color, redness, blistering, swelling, and others. Furthermore, retinoids are also used to treat pigmentary disorders like post-inflammatory hyperpigmentation, actinic lentiginous, and melasma.

The increasing burden associated with acne leads patients to seek professional help in the form of prescription treatments. This is further expected to boost the growth of the segment. It is observed that dermatologists prefer to treat skin problems through less invasive procedures or topical applications compared with surgical methods.

Antibiotics are often used to treat acne since they help decrease bacteria and encompass the pilosebaceous unit, consisting of a sebaceous gland and hair follicle. Acne is caused by the effects of hormones on this unit. Precisely, the follicle becomes obstructed, and an excess of normal skin bacteria, Propionibacterium acnes, destroys the lining of the follicle. This process allows the follicular material to enter the dermis, causing an inflammatory response. Antibiotics work by several mechanisms. The most prominent mechanism is the decrease in the number of bacteria in and around the follicle. Antibiotics also work by decreasing the irritating chemicals produced by white blood cells. Antibiotics reduce the collection of free fatty acids in the sebum, also reducing the inflammatory response. This factor is driving the growth of the segment in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global acne drugs market

North America dominates the market due to lifestyle changes, rising disease incidence, and easy availability of products. In addition, more informed decision making, better patient-physician relationships and well-documented procedures lead to increasing demand for treatments for face and skin-related problems. This has been driving the adoption of several less painful aesthetic combination therapy methods. Further, growing demand for faster treatments and faster results are factors anticipated to drive demand in the region.

Factors such as hormonal changes that occur with hereditary aspects, puberty, and sedentary lifestyles are prevalent in the 10-16 years of age. According to the American Academy of Dermatology, almost 100% of all teenagers go through occasional acne breakouts. These factors are driving the growth of the market in the region.

Competitive Landscape

The acne drugs market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Johnson & Johnson, Allergan plc, Galderma S.A., Reckitt Benckiser Group, Guthy-Renker, Stiefel Laboratories, Valeant Pharmaceuticals, Bayer AG, China Kouting Group Limited, Medical Materials & Accessories among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the acne drugs market globally.

Acne Drugs Market Key Companies to Watch

Allergan plc

Overview: Allergan PLC manufactures specialty pharmaceuticals. The Company develops, manufactures, and distributes generic, brand, and over-the-counter products. Allergan offers its pharmaceutical drugs around the world. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States. Within its US Specialized Therapeutics, US General Medicine and International operations, the Company sells its brand and aesthetic pharmaceutical products primarily to drug wholesalers, retailers and distributors, including national retail drug and food store chains, hospitals, clinics, mail-order retailers, government agencies and managed healthcare providers, such as health maintenance organizations and other institutions.

Product Portfolio: The Company's portfolio comprised of medical aesthetics, eye care, central nervous system and gastroenterology, the company also manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Key Development: In March 2019, Allergan acquired Envy Medical Inc. This deal will help Allergan reinforce their goal towards providing customers with enhanced skin care solutions. Envy medicals' technology used in skin resurfacing procedures like Dermalinfusion, which is a non-surgical, non-invasive skin resurfacing system will immensely help Allergan gain a strong presence in the acne market.

Why Purchase the Report?

  • Visualize the composition of the acne drugs market segmentation by type, therapeutic class, route of administration and distribution channel highlighting the key commercial assets and players.
  • Identify commercial opportunities in acne drugs market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of acne drugs market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global acne drugs market report would provide an access to an approx. 67 market data table, 64 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Acne Drugs Market - By Type

  • Comedonal
  • Inflammatory
  • Cystic
  • Postsurgical/wound

Global Acne Drugs Market - By Therapeutic Class

  • Retinoid
  • Antibiotic
  • Hormonal Agent
  • Combination
  • Others

Global Acne Drugs Market -By Route of Administration

  • Topical
  • Oral
  • Injectable

Global Acne Drugs Market - By Distribution Channel

  • Retail Store
  • Pharmacy & Drug Store
  • Online Stores

Global Acne Drugs Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Acne Drugs Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Acne Drugs Market - Market Definition and Overview

3. Global Acne Drugs Market - Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Therapeutic Class
  • 3.3. Market Snippet by Route of Administration
  • 3.4. Market Snippet By Distribution Channel
  • 3.5. Market Snippet by Region

4. Global Acne Drugs Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence and severity of acne globally will drive the market
      • 4.1.1.2. Unhygienic lifestyle and excessive production of oil from sebaceous glands
    • 4.1.2. Restraints:
      • 4.1.2.1. Risks associated with use is likely to hinder the market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Acne Drugs Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Acne Drugs Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Acne Drugs Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Comedonal *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Inflammatory
  • 7.4. Cystic
  • 7.5. Postsurgical/wound

8. Global Acne Drugs Market - By Therapeutic Class

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Class
    • 8.1.2. Market Attractiveness Index, By Therapeutic Class
  • 8.2. Retinoid *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Antibiotic
  • 8.4. Hormonal Agent
  • 8.5. Combination
  • 8.6. Others

9. Global Acne Drugs Market - By Route of Administration

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 9.1.2. Market Attractiveness Index, By Route of Administration
  • 9.2. Topical*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Oral
  • 9.4. Injectable

10. Global Acne Drugs Market - By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
    • 10.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 10.2. Retail Store *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Pharmacy & Drug Store
  • 10.4. Online Stores

11. Global Acne Drugs Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Class
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Class
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Class
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Class
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Class
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Global Acne Drugs Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of key companies to watch
  • 12.5. List of the company with disruptive technology
  • 12.6. List of start-up companies

13. Global Acne Drugs Market- Company Profiles

  • 13.1. Johnson & Johnson *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Allergan plc
  • 13.3. Galderma S.A
  • 13.4. Reckitt Benckiser Group
  • 13.5. Guthy-Renker
  • 13.6. Stiefel Laboratories
  • 13.7. Valeant Pharmaceuticals
  • 13.8. Bayer AG,
  • 13.9. China Kouting Group Limited
  • 13.10. Medical Materials

LIST NOT EXHAUSTIVE

14. Global Acne Drugs Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us